Scholars Central

Conference abstract

An open-label, randomized, pivotal bioequivalence study of oral Rolapitant in healthy subjects

Authors: Xiaodong Wang, Zhi-Yi Zhang, Sujata Arora, Jing Wang, Sharon Lu, Vikram Kansra

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Rolapitant (VARUBI®/VARUBY®), a selective and long-acting neurokinin-1 receptor antagonist, is approved in oral formulation for the prevention of delayed chemotherapy-induced nausea and vomiting in adults in US and EU. This pivotal open-label, randomized, single-dose, multicenter, parallel-group study assessed the bioequivalence of a single oral dose of 180 mg Rolapitant administered as tablets (2Ã?90 mg tablets, commercial formulation) or capsules (4Ã?45 mg capsules, formulation used in clinical development) in healthy subjects. Blood samples for pharmacokinetic analysis were collected pre-dose and at multiple time points up to 912 hours post-dose. The pharmacokinetic analysis of the capsule group (n=42) and tablet group (n=42) were similar. The Rolapitant tablet was considered bioequivalent to the Rolapitant capsule if the 90% confidence intervals for the ratios of the geometric means for Rolapitant, observed maximum plasma concentration (Cmax) and area under the curve (AUC0-â??) were within the 0.80-1.25 range. The geometric mean ratios of Cmax and AUC0-â?? were 0.99 (0.89-1.11) and 1.05 (0.92-1.19), respectively, establishing bioequivalence of the Rolapitant tablet and capsule and suggesting that data obtained during clinical development is translatable to the commercial formulation. Both formulations were well tolerated, with a similar incidence of treatment-emergent adverse events in the two groups.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Xiaodong Wang”
  • BylineArticles whose byline prints “Zhi-Yi Zhang”
  • BylineArticles whose byline prints “Sujata Arora”
  • BylineArticles whose byline prints “Jing Wang”
  • BylineArticles whose byline prints “Sharon Lu”
  • BylineArticles whose byline prints “Vikram Kansra”